United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$355.93 USD
+5.86 (1.67%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $355.74 -0.19 (-0.05%) 7:24 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (89 out of 251)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.79 | 1.55 | 9.99 |
Current Quarter Estimate | 6.15 | 0.44 | 61.00 |
Year Ago Quarter Estimate | 5.38 | 0.11 | 54.84 |
Next Quarter Estimate | 6.47 | -1.66 | 63.00 |
Next Year Estimate | 27.41 | 13.59 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 24.73 | 19.40 | 15.67 |
Next Year | 10.93 | 16.40 | 11.34 |
Last 5 Years | 21.80 | 7.80 | 8.10 |
Next 5 Years | 11.10 | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 16.09 | -2.64 |
Price/Book (MRQ) | 2.73 | 1.51 |
Price/Cash Flow (MRFY) | 15.85 | 8.65 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 40.87% | -56.43% |
Return on Equity (TTM) | 18.82% | -58.58% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.